Latest Data of InnoCare’s Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...